Atlas Trials

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes

Clinical trial NCT01140893 · UNKNOWN

Trial details

NCT number
NCT01140893
Sponsor
University Hospital, Caen
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2010-11-01
Primary completion
2017-05-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.